Send us a text

This week's MedEvidence Monday Minute conversation takes an exciting turn as Kevin Geddings and Dr. Michael Koren discuss the realm of Alzheimer's disease, exploring a promising new FDA approved drug and the hope it carries for affected patients. Dr. Koren gave us insight into how this drug may decelerate the progression of Alzheimer's symptoms and its impact on brain plaques. Shifting our attention to the alarming rise of COVID-19 cases in Florida, Dr. Koren issues a warning about the potential of the virus becoming endemic. Still, he also provides a glimmer of hope, introducing us to the possibility of antibody treatments for those ineligible for vaccination. Tune in for an enlightening conversation that navigates through medical breakthroughs and the challenging realities of the healthcare landscape.

Recording Date: July 10, 2023

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!